(2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide
C19H31N5O4S — CID 155880635
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide
(2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide (PubChem CID 155880635) has the molecular formula C19H31N5O4S and a molecular weight of 425.56 g/mol. Its IUPAC name is (2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 155880635 |
| Molecular Formula | C19H31N5O4S |
| Molecular Weight | 425.56 g/mol |
| Exact Mass | 425.21 |
| IUPAC Name | (2S,4R)-N-cyclohexyl-4-hydroxy-1-[1-(1H-imidazol-5-ylsulfonyl)piperidin-4-yl]pyrrolidine-2-carboxamide |
| SMILES | O=C(NC1CCCCC1)[C@@H]1C[C@@H](O)CN1C1CCN(S(=O)(=O)c2cnc[nH]2)CC1 |
| InChI | InChI=1S/C19H31N5O4S/c25-16-10-17(19(26)22-14-4-2-1-3-5-14)24(12-16)15-6-8-23(9-7-15)29(27,28)18-11-20-13-21-18/h11,13-17,25H,1-10,12H2,(H,20,21)(H,22,26)/t16-,17+/m1/s1 |
| InChIKey | LUXIJVMFGRJASG-SJORKVTESA-N |
| XLogP | 0.45 |
| TPSA | 118.63 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.56 |
| LogP ≤ 5 | 0.45 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155880635 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.